TechNavio today launched its report Global Intravenous Solutions Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; ”The Global Intravenous Solutions market is experiencing some important trends that are contributing to the growth of the market. One of the major trends is the significant increase in the number of corporate agreements. For instance, Abu Dhabi Investment House (ADIH) (investment manager of Wellpharma Medical Solutions Inc.) teamed up with Bram S.p.A. to build an intravenous manufacturing and distribution plant in Abu Dhabi in October 2010.”
According to the report, one of the major growth factors driving the market is the significant increase in the number of out-patient therapies. Along with the increasing preference of patients for home healthcare, hospitals are also eagerly providing out-patient services to reduce the time patients stay in hospitals, which consumes both space and staff time.
Further, the report also discusses that the high cost of intravenous analgesic drugs is expected to affect the growth of the Global Intravenous Solutions market over the period 2011-2015.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/global-intravenous-solutions-market-201…
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report – Global Intravenous Solutions Market 2011-2015
